Boosting Mitochondrial Function May Nullify Resistance to Radiotherapy
By MedImaging International staff writers Posted on 10 Dec 2013 |
The resistance of some cancers to the cell-destroying effects of radiation therapy may be caused by mitochondrial abnormalities, according to an international team of researchers.
These findings were published November 25, 2013, in the journal Developmental Cell. Dr. Maxim Frolov, associate professor of biochemistry and molecular genetics at the University of Illinois at Chicago (UIC; IL, USA), and colleagues studied the effects of a gene mutation called E2F, which regulated other genes responsible for triggering programmed cell death, a normal function in most cells. Cells undergo apoptosis when they are no longer needed, as a normal part of aging, or in response to environmental factors like radiation that damage cellular DNA.
When Dr. Frolov and colleagues exposed fruit flies with a mutant E2F gene to radiation, genes that trigger apoptosis were initiated, but the flies did not die. “Something else was preventing the flies from dying, even though the genes needed to undergo cell death were turned on,” Dr. Frolov said.
Looking closer inside, the cells of the flies revealed that their mitochondria were misshapen and produced less energy than normal mitochondria. Flies with the most severely unstable mitochondria were the most resistant to radiation-induced cell death. The observation in fruit flies suggested an earlier unknown role for the E2F transcription factor (the protein encoded by E2F that regulates expression of other genes) in mitochondrial function. “It seems their mitochondria were also affected by the E2F mutation and were not functioning at full strength,” said Dr. Frolov. “You need properly functioning mitochondria to carry out programmed cell death.”
Regarding human cells, the researchers discovered the same effects: those without the E2F gene were resistant to the effects of radiation. Dr. Frolov reported that the similarity in the findings revealed that basic cellular functions do not alter much across the huge evolutionary expanse between fruit flies and humans. “This result highlights a remarkable degree of conservation between fruit flies and humans and illustrates the advantages of using model organisms in cancer research,” said Dr. Frolov, whose laboratory is part of the UIC Cancer Center.
Dr. Frolov and his colleagues believe that dysfunctional mitochondria might be the cause of the differences in how patients respond to radiation therapy. Earlier research has suggested that the inability of some patients’ mitochondria to support apoptosis might account for disparities in their response to chemotherapy for acute myelogenous leukemia. “If we could develop a small-molecule drug that could enhance mitochondrial function in these patients, we may be able to improve the effectiveness of radiation therapy,” concluded Dr. Frolov.
Related Links:
University of Illinois at Chicago
These findings were published November 25, 2013, in the journal Developmental Cell. Dr. Maxim Frolov, associate professor of biochemistry and molecular genetics at the University of Illinois at Chicago (UIC; IL, USA), and colleagues studied the effects of a gene mutation called E2F, which regulated other genes responsible for triggering programmed cell death, a normal function in most cells. Cells undergo apoptosis when they are no longer needed, as a normal part of aging, or in response to environmental factors like radiation that damage cellular DNA.
When Dr. Frolov and colleagues exposed fruit flies with a mutant E2F gene to radiation, genes that trigger apoptosis were initiated, but the flies did not die. “Something else was preventing the flies from dying, even though the genes needed to undergo cell death were turned on,” Dr. Frolov said.
Looking closer inside, the cells of the flies revealed that their mitochondria were misshapen and produced less energy than normal mitochondria. Flies with the most severely unstable mitochondria were the most resistant to radiation-induced cell death. The observation in fruit flies suggested an earlier unknown role for the E2F transcription factor (the protein encoded by E2F that regulates expression of other genes) in mitochondrial function. “It seems their mitochondria were also affected by the E2F mutation and were not functioning at full strength,” said Dr. Frolov. “You need properly functioning mitochondria to carry out programmed cell death.”
Regarding human cells, the researchers discovered the same effects: those without the E2F gene were resistant to the effects of radiation. Dr. Frolov reported that the similarity in the findings revealed that basic cellular functions do not alter much across the huge evolutionary expanse between fruit flies and humans. “This result highlights a remarkable degree of conservation between fruit flies and humans and illustrates the advantages of using model organisms in cancer research,” said Dr. Frolov, whose laboratory is part of the UIC Cancer Center.
Dr. Frolov and his colleagues believe that dysfunctional mitochondria might be the cause of the differences in how patients respond to radiation therapy. Earlier research has suggested that the inability of some patients’ mitochondria to support apoptosis might account for disparities in their response to chemotherapy for acute myelogenous leukemia. “If we could develop a small-molecule drug that could enhance mitochondrial function in these patients, we may be able to improve the effectiveness of radiation therapy,” concluded Dr. Frolov.
Related Links:
University of Illinois at Chicago
Latest Nuclear Medicine News
- New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy
- New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment